Zypadhera - direct healthcare professional communication (DHPC)

olanzapine pamoate monohydrate

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Zypadhera (olanzapine pamoate monohydrate): Injection kits to temporarily include only three 38 mm safety needles instead of two 38 mm and two 50 mm safety needles

Dissemination date: 19/06/2024

Key facts

• Medicine name:
  Zypadhera
• Active substance:
  olanzapine pamoate monohydrate
• Therapeutic area (MeSH):
  Schizophrenia
• DHPC type:
  Quality defect
• Human ATC codes:
  N05AH03
• Dissemination date:
  19/06/2024